Deal Library / Pharma BD Deal Intelligence

Bristol Myers Squibb — Pharma Deals

The Pharma Closeout tracks 17 deals, $905M in disclosed deal value for Bristol Myers Squibb.

All 17 deals

• Bristol Myers Squibb / Oxford BioTherapeutics — 2026
• Bristol Myers Squibb / Chai Discovery, Inc. — 2026
• Bristol Myers Squibb / Prothena Corporation plc — 2024
• Bristol Myers Squibb / Karyopharm — 2023
• Bristol Myers Squibb / Zenas BioPharma — 2023
• Bristol Myers Squibb / BridgeBio Pharma, Inc. — 2022 · $905M
• Bristol Myers Squibb / SyntheX, Inc. — 2022
• Bristol Myers Squibb / Antengene Corporation Limited — 2021
• Bristol Myers Squibb / Molecular Templates, Inc. — 2021
• Bristol Myers Squibb / Bolt Biotherapeutics, Inc. — 2021
• Bristol Myers Squibb / Janssen Pharmaceutical Companies of Johnson & Johnson — 2018
• Bristol Myers Squibb / Compugen — 2018
• Bristol Myers Squibb / Infinity Pharmaceuticals — 2018
• Bristol Myers Squibb / Array BioPharma — 2017
• Bristol Myers Squibb / Calithera Biosciences — 2016
• Bristol Myers Squibb / Enterome — 2016
• Bristol Myers Squibb / Rigel Pharmaceuticals — 2015

← Deal Library  ·  Interactive search  ·  How we score deals